Alphamab Oncology (FRA:3NK)
Germany · Delayed Price · Currency is EUR 0.9600
0.00 (0.00%)
At close: Jan 27, 2026
Alphamab Oncology Market Cap
Alphamab Oncology has a market cap or net worth of €930.1 million as of January 30, 2026. Its market cap has increased by 129.06% in one year.
Market Cap
930.10M
Enterprise Value
768.15M
Revenue
93.42M
Ranking
n/a
PE Ratio
33.61
Stock Price
€0.96
Market Cap Chart
Since December 12, 2019, Alphamab Oncology's market cap has decreased from 1.40B to 930.10M, a decrease of -33.34%. That is a compound annual growth rate of -6.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 930.10M | -10.45% |
| Dec 31, 2025 | 1.04B | 147.98% |
| Dec 31, 2024 | 418.85M | -43.55% |
| Dec 29, 2023 | 741.95M | -39.08% |
| Dec 30, 2022 | 1.22B | -15.24% |
| Dec 31, 2021 | 1.44B | -10.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 688.26M |